Ubs Group Ag Pure Tech Health PLC Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Pure Tech Health PLC stock. As of the latest transaction made, Ubs Group Ag holds 647 shares of PRTC stock, worth $12,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
647
Previous 351
84.33%
Holding current value
$12,622
Previous $8,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PRTC
# of Institutions
5Shares Held
28.7KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL25KShares$487,7500.01% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3KShares$58,5300.01% of portfolio
-
Morgan Stanley New York, NY100Shares$1,9510.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $544M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...